AR037505A1 - Un articulo absorbente que comprende una cantidad efectiva de un primer ingrediente activo, una composicion para inhibir la produccion de exoproteina de bacterias grampositivas y un metodo para inhibir dicha produccion de exoproteina - Google Patents

Un articulo absorbente que comprende una cantidad efectiva de un primer ingrediente activo, una composicion para inhibir la produccion de exoproteina de bacterias grampositivas y un metodo para inhibir dicha produccion de exoproteina

Info

Publication number
AR037505A1
AR037505A1 ARP020103716A ARP020103716A AR037505A1 AR 037505 A1 AR037505 A1 AR 037505A1 AR P020103716 A ARP020103716 A AR P020103716A AR P020103716 A ARP020103716 A AR P020103716A AR 037505 A1 AR037505 A1 AR 037505A1
Authority
AR
Argentina
Prior art keywords
inhibit
unsaturated aliphatic
aliphatic hydrocarbyl
saturated
effective amount
Prior art date
Application number
ARP020103716A
Other languages
English (en)
Inventor
Worldwide Inc Kimberly-Clark
Original Assignee
Kimberly Clark Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/969,299 external-priority patent/US20030135173A1/en
Priority claimed from US09/969,391 external-priority patent/US7022333B2/en
Priority claimed from US09/969,218 external-priority patent/US7026354B2/en
Application filed by Kimberly Clark Co filed Critical Kimberly Clark Co
Publication of AR037505A1 publication Critical patent/AR037505A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Absorbent Articles And Supports Therefor (AREA)

Abstract

Se describen artículos absorbentes y no absorbentes. Los artículos incluyen una cantidad efectiva de un compuesto inhibidor aromático para inhibir sustancialmente la producción de exotoxinas por bacterias grampositivas. Los compuestos inhibidores aromáticos de la presente tienen la fórmula general (1), en donde: R1 es seleccionado del grupo que consiste en H, -(O)=COR5, -OR5, -R6C(O)H, -R6OH, -R6COOH, -OR6OH, -OR6COOH, -C(O)NH2, -HNC(O)R5, -(NH2)R7OH, -(NH2)R7COOH, -(NHR8)R7OH, -(NHR8)R7COOH, y NH2 y las sales del mismo; R5 es una mitad de hidrocarbilo alifática saturada o insaturada monovalente, R6 es una mitad de hidrocarbilo alifática saturada o insaturada divalente; R7 es una mitad de hidrocarbilo alifática saturada o insaturada trivalente; R8 es una mitad de hidrocarbilo alifática saturada o insaturada sustituida o no sustituida monovalente la cual puede o no ser interrumpida con heteroátomos; R2, R3 y R4 son seleccionados independientemente del grupo que consiste en H, OH, COOH, y -C(O)R9, R9 es hidrógeno o una mitad de hidrocarbilo alifática saturada o insaturada monovalente.
ARP020103716A 2001-10-02 2002-10-02 Un articulo absorbente que comprende una cantidad efectiva de un primer ingrediente activo, una composicion para inhibir la produccion de exoproteina de bacterias grampositivas y un metodo para inhibir dicha produccion de exoproteina AR037505A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/969,299 US20030135173A1 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in absorbent articles using aromatic compositions
US09/969,391 US7022333B2 (en) 2001-10-02 2001-10-02 Inhibition of exoprotein production in non-absorbent articles uisng aromatic compositions
US09/969,218 US7026354B2 (en) 2001-10-02 2001-10-02 Aromatic compositions for the inhibition of exoprotein production from gram positive bacteria

Publications (1)

Publication Number Publication Date
AR037505A1 true AR037505A1 (es) 2004-11-17

Family

ID=27420759

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP020103716A AR037505A1 (es) 2001-10-02 2002-10-02 Un articulo absorbente que comprende una cantidad efectiva de un primer ingrediente activo, una composicion para inhibir la produccion de exoproteina de bacterias grampositivas y un metodo para inhibir dicha produccion de exoproteina

Country Status (9)

Country Link
EP (1) EP1432459A1 (es)
JP (1) JP2005523239A (es)
KR (1) KR100918887B1 (es)
AR (1) AR037505A1 (es)
AU (1) AU2002336472B2 (es)
BR (1) BR0212679A (es)
CA (1) CA2461291A1 (es)
MX (1) MXPA04002474A (es)
WO (1) WO2003030953A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009007799B4 (de) * 2009-02-06 2010-10-14 ITM Isotopen Technologien München AG Molekül zur Funktionalisierung eines Trägers, Bindung eines Radionuklids an den Träger und Radionuklidgenerator zur Herstellung des Radionuklids sowie Herstellungsverfahren
EP3223764B1 (en) * 2014-11-27 2023-10-25 Yeditepe Universitesi Antimicrobial and antiviral hygienic products
WO2018064978A1 (zh) * 2016-10-09 2018-04-12 曾忠铭 一种抑菌剂配伍在制备阴道用组合物中的用途与阴道用组合物

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317376A (en) * 1963-02-12 1967-05-02 Robert I Schattner Germicidal fabric
IL55214A (en) * 1978-07-25 1981-07-31 Abic Ltd Antibacterial compositions containing trimethoprim and other ingredients
DE3204124A1 (de) * 1982-02-06 1983-08-18 Bayer Ag, 5090 Leverkusen Antimykotische tampons mit hoher wirkstoff-freisetzung
US4560549A (en) * 1983-08-24 1985-12-24 Lever Brothers Company Method of relieving pain and inflammatory conditions employing substituted salicylamides
GB2186486B (en) * 1986-02-13 1989-11-08 Smith & Nephew Ass Antibacterial dressing
US5180749A (en) * 1989-08-22 1993-01-19 Sterling Winthrop, Inc. Antimicrobial composition
US5476455A (en) * 1993-01-11 1995-12-19 Silber; Arthur L. Toxicity resistant tampon structure
DE4411664A1 (de) * 1994-04-05 1995-10-12 Beiersdorf Ag Neue desodorierende und antimikrobielle Zusammensetzungen zur Verwendung in kosmetischen oder topischen Zubereitungen
JPH07289575A (ja) * 1994-04-27 1995-11-07 Okamoto Ind Inc 香料添加コンドーム及びコンドームへの香料添加方法
US5668097A (en) * 1994-08-12 1997-09-16 The Procter & Gamble Company Uncomplexed cyclodextrin solutions for odor control on inanimate surfaces
DE4434781A1 (de) * 1994-09-29 1996-04-04 Beiersdorf Ag Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen
AU6253996A (en) * 1995-06-07 1996-12-30 Kimberly-Clark Worldwide, Inc. Inhibition of exoprotein in absorbent article
JPH09108257A (ja) * 1995-10-23 1997-04-28 Shiyouichi Masugi 蓄光性クリーム及びラテックス製コンドーム
GB9612595D0 (en) * 1996-06-15 1996-08-21 Smithkline Beecham Plc Composition
WO1998011888A1 (en) * 1996-09-19 1998-03-26 American Home Products Corporation Method of treating urinary incontinence
ES2255730T3 (es) * 1997-04-18 2006-07-01 Ganeden Biotech, Inc. Utilizacion topica de esporas de bacilos probioticos para prevenir o tratar las infecciones microbianas.
KR20010013377A (ko) * 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
US6353004B1 (en) * 1997-07-14 2002-03-05 Adolor Coporation Peripherally acting anti-pruritic opiates
AU5930898A (en) * 1998-01-28 1999-08-16 Procter & Gamble Company, The Antimicrobial hydrogel forming absorbent polymers
EP1024808A1 (en) * 1998-04-11 2000-08-09 Errekappa Euroterapici S.p.a. Pharmaceutical preparations containing hydrosoluble ketoprofen salts and their application
FR2777783A1 (fr) * 1998-04-24 1999-10-29 Innothera Lab Sa Association pharmaceutique d'imidazoles pour le traitement local des vulvo-vaginites infectieuses et des vaginoses
KR100563881B1 (ko) * 1998-05-29 2006-03-28 킴벌리-클라크 월드와이드, 인크. 천연 및 합성 중합체에 의한 향상된 냄새 흡수

Also Published As

Publication number Publication date
WO2003030953A1 (en) 2003-04-17
KR100918887B1 (ko) 2009-09-23
EP1432459A1 (en) 2004-06-30
CA2461291A1 (en) 2003-04-17
BR0212679A (pt) 2005-04-12
KR20040044950A (ko) 2004-05-31
JP2005523239A (ja) 2005-08-04
MXPA04002474A (es) 2004-05-31
AU2002336472B2 (en) 2007-08-23

Similar Documents

Publication Publication Date Title
HRP20031098B1 (en) Beta-amino tetrahydroimidazo (1,2-a) pyrazines and tetrahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
ES2091180T3 (es) Derivados del acido 7-piperazinil- o 7-morfolino-4-oxo-quinolino-3-carboxilico, su preparacion y su utilizacion como agentes antimicrobianos.
RS20060699A (en) Isoxazolines for controlling inverterbrate pests
DK1322648T3 (da) 3-(heteroarylacetamido)-2-oxo-azetidin-1-sulfonsyrederivater som antibakterielle midler
ATE482616T1 (de) Zusammensetzungen mit hoher antiviraler und antibakterieller wirkung
NO20060653L (no) Isotiazolokinoloner og beslektede forbindelser som anti-infektive midler
MY102919A (en) Pleuromutilin derivatives process for their preparation and their use.
AR022300A1 (es) Composicion adyuvante
PE20030763A1 (es) Inhibidores de la integrasa del vih
MX9100607A (es) Compuesto triciclico novedoso o sales del mismo,metodo para producir el mismo y agente antimicrobiano que lo contiene
GT200100251A (es) Procedimiento para la preparacion de imidazotriazinonas substituidas con sulfonamida
EA200501888A1 (ru) Замещённые пиразолопиримидины, способ их получения и их применение для борьбы с патогенными грибами, а также содержащие их средства
AR037505A1 (es) Un articulo absorbente que comprende una cantidad efectiva de un primer ingrediente activo, una composicion para inhibir la produccion de exoproteina de bacterias grampositivas y un metodo para inhibir dicha produccion de exoproteina
BR0111876A (pt) Processo para preparação de ésteres de ácido hidroxifenilcarboxìlico
WO2003022797A1 (fr) Derives de carba-sucres amine et traitements du trouble du metabolisme des glycolipides les contenant en tant qu'ingredient actif
US4447366A (en) Derivatives of lysine and aspartic acid
AR025379A1 (es) 9a-azalidas con actividad antibacteriana.
AR029002A1 (es) Proceso para preparar compuestos de acidos quinolin-2-carboxilicos y de sus sales farmaceuticamente aceptables
AR031712A1 (es) Metodo y composicion
MX2012008389A (es) Metodos para producir compuestos glicolipidos sustituidos con aminas.
PE20080699A1 (es) Azalidas 9a-sustituidas con actividad antimalarica
AR127435A1 (es) Compuestos piperazinilsulfonilarilo para el tratamiento de infecciones bacterianas
HUT44418A (en) Activated fungicide comprising substituted 1,2,4-triazoles as active substance and process for preparing morpholinearyl sulfonates used as activator
AR015580A1 (es) Procedimiento e intermedio para la preparacion de derivados de 2-fluorotiofeno
AR029004A1 (es) Compuesto del acido 7-acilamino-3-heteroariltio-3-cefem carboxilico y su uso para la preparacion de una composicion antibacteriana

Legal Events

Date Code Title Description
FA Abandonment or withdrawal